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D
ry eye syndrome is a multifactorial condition characterized by eye irritation symptoms, blurred and fluctuating vision, tear film instability, increased tear osmolarity, and ocular surface epithelial syndrome. [1] [2] [3] [4] Diabetes mellitus has been shown to be associated with and complicated by dry eye syndrome. Diabetic patients frequently complain of symptoms typical of dry eye syndrome, such as burning and foreign body sensation. 5, 6 The manifestations of diabetes mellitus resultant from lacrimal gland and ocular surface dysfunctions appear to be related to dry eye syndrome. 7, 8 Manaviat et al. 9 showed that approximately half (54.3%, 108/199) of diabetic patients suffered from dry eye syndrome, and there was a significant association between dry eye syndrome and duration of diabetes. Jin et al. 10 also showed that patients with type 2 diabetes tend to have tear film dysfunction. Dry eye can lead to vision deficit, scarring and perforation of the cornea, and secondary bacterial infection. If this syndrome is diagnosed at the early stage and treated promptly, undesirable complications can be avoided or minimized. Therefore, early diagnosis and treatment of dry eye syndrome in type 2 diabetic patients is very important.
Tears contain a variety of substances, including proteins, lipids, mucins, salts, and other organic molecules, and tear proteins are believed to have key roles in protecting the ocular surface from external insults, such as pathogenic infections, and promoting ocular wound healing. Recently, electrospray ionization (ESI) mass spectrometry (MS)/MS was used to identify some novel species in the tears. [11] [12] [13] [14] The number of proteins found in the tear film continues to grow, and Fung et al. 15 reported that approximately 500 proteins were detected and unambiguously identified by liquid chromatography (LC)/ MS/MS However, there still is lack of agreement in the literature regarding the number of proteins in the tear film and the functions of individual proteins. Lactoperoxidase, lysozyme C, and elastase 2 are found to protect the ocular surface against antimicrobial infection or inflammation, and some other proteins, like cathepsin B, are related to ocular surface wound healing, or stability promoting through interaction with other ligands. 16, 17 In our study, we sought to examine and compare the tear film proteome of type 2 diabetic patients with or without dry eye syndrome and normal subjects using two- 
SUBJECTS AND METHODS

Subjects
We included in our study eight patients with type 2 diabetes with dry eye syndrome and eight patients with type 2 diabetes without dry eye syndrome. Type 2 diabetes was diagnosed according to the criteria of the World Health Organization (WHO). 18 Dry eye syndrome was diagnosed by a modified Dry Eye Workshop classification 19 and was considered present if Shirmer I test < 5 mm and tear breakup time (BUT) < 5 seconds, and absent if Shirmer I test > 10 mm and BUT > 10 seconds. A subject was included if he or she was aged between 50 and 60 years, and if he or she had type 2 diabetes of more than 5 years. A subject was excluded if he or she used eye drops within one month before the study, had a history of ocular surgery, had systemic immunologic syndromes, or had any ocular syndromes other than dry eye syndrome. In addition, eight age-and sex-matched healthy subjects were included as normal controls. The study protocol was approved by the Institutional Review Board of Shanghai Tenth People's Hospital and all study participants provided written informed consent. The study was carried out in accordance with the Declaration of Helsinki.
Tear Sample Collection and Preparation
Tears were collected by placing a Schirmer strip over the lower lid approximately 6 mm from the lateral canthus. The lid was not anesthetized. The subjects were instructed to keep eyes closed during the 5-minute test. After wet length was recorded, the strip was placed in a 1-mL amber Eppendorf tube. The samples were placed immediately in ice transport tanks for transfer to the Chinese National Human Genome Center at Shanghai, where the samples were stored at À808C until processed. Proteins were extracted from the Schirmer strip by incubation in 1 mL Tris buffer (pH ¼ 8.3, 7 M urea, 5 mM ethylenediaminetetraacetic acid [EDTA], 1 mM phenylmethylsulfonyl fluoride [PMSF] , and 0.5 mM dichlorodiphenyltrichloroethane [DTT]) at 48C for 10 hours. After centrifugation at 12,000g for 10 minutes, the supernatants from all patients within each group were pooled and precipitated by acetone as described previously. 20 Precipitated proteins were resuspended in 100 lL Tris buffer and quantitated using the BCA assay kit (Pierce, Rockford, IL). The normalized protein content in the tear samples was calculated using the following formula:
Normalized protein content ¼ total protein= filter paper wet length in Schirmer I test: Then, 12.5 lg protein from each group were incubated with 25 mM ammonium bicarbonate and 10 mM DTT for 60 minutes at 568C followed by incubation with 25 mM indoleacetic acid (IAA) for 30 minutes in the dark at room temperature. Trypsin digestion was done at 378C for 12 hours. The resultant peptides were dried and saved at À808C.
Two-Dimensional Strong Cation-Exchange/ Reversed-Phase Nano-Scale LC MS Extracted peptides were desalted using a 1.3 mL C18 solid phase extraction column (Sep-Pak Cartridge; Waters, Milford, MA) and dried using a vacuum centrifuge (Eppendorf, Westbury, NY), and then resuspended with loading buffer (5 mM ammonium formate containing 5% acetonitrile, pH 3.0), separated, and analyzed by 2D-LC-nano-MS/MS. The experiments were performed on a Nano Aquity UPLC system (Waters) connected to an LTQ Orbitrap XL mass spectrometer (Thermo Electron, Bremen, Germany) equipped with an online nano-electrospray ion source (Michrom Bioresources, Auburn, CA). A 180 lm 3 2.4 cm SCX column (Waters), which was packed with a 5-lm PolySULFOETHYL Aspartamide (PolyLC, Columbia, MD) was used for the first dimension. For recovery of hydrophobic peptides retained on the SCX column after a conventional salt step gradient, an RP step gradient from 15% to 50% acetonitrile was applied to the SCX column.
19 A 9-lL plug was injected each time to form the step gradients ( Table  1 ). The SCX column finally was cleaned with 1 M ammonium formate (NH 4 FA) twice. The plugs were loaded onto the SCX column with a loading buffer at a 4 lL/min flow rate for 4 minutes. A 9-lL peptide sample was loaded onto the SCX column before the gradient plugs were injected. Eluted peptides were captured by a trap column (Waters), while salts were diverted to waste. The trap column (2 cm 3 180 lm) was packed with a 5-lm Symmetry C18 material (Waters). The RP analytical column (20 cm 3 75 lm) was packed with a 1.7-lm Bridged Ethyl Hybrid (BEH) C18 material (Waters), and was used for the second dimension separation.
Peptides on the RP analytical column were eluted with a three-step linear gradient, starting from 5% B to 45% B in 40 minutes (A, water with 0.1% formic acid; B, acetonitrile with 0.1% formic acid), increased to 80% B in 3 minutes, and then to 5% B in 2 minutes. The column was reequilibrated at initial conditions for 15 minutes. The column flow rate was maintained at 300 nL/min and column temperature was maintained at 358C. The electrospray voltage of 1.1 kV versus the inlet of the mass spectrometer was used.
An LTQ Orbitrap XL mass spectrometer (Thermo Electron) was operated in the data-dependent mode to switch automatically between MS and MS/MS acquisition. Survey full-scan MS spectra with two microscans (m/z 300-1800) were acquired in the Obitrap with a mass resolution of 60,000 at 400 m/z, followed by 10 sequential LTQ-MS/MS scans. Dynamic exclusion was used with two repeat counts, 10-second repeat duration, and 60-second exclusion duration. For MS/MS, precursor ions were activated using 35% normalized collision energy at the default activation q of 0.25.
Data Analyses
All MS/MS spectra were identified by using SEQUEST (v.28 [revision 12]; Thermo Electron) against the human International Protein Index (IPI) database (IPI human v3.45 fasta with 71983 entries). To reduce false-positive identification results, a decoy database containing the reverse sequences was appended to the database. The searching parameters were set up as follows: partial trypsin (KR) cleavage with two missed cleavages was considered, the variable modification was oxidation of methionine, peptide mass tolerance was 20 parts per million (ppm), and fragment ion tolerance was 1 Da. The Trans Proteomic Pipeline software (revision 4.0; Institute of Systems Biology, Seattle, WA) then was used to identify proteins based upon corresponding peptide sequences with ‡95% confidence. The peptides results were filtered by the Peptide Prophet 21 with a P value over 0.95 and a Protein Prophet 22 probability of 0.95 was used for the protein identification results. Spectral counts (SC) correlate with protein abundance. 23 The relative abundance of individual proteins was assessed by spectral counting, in which we counted how many times the unlabeled version of a protein was identified by the fragmentation spectra of its peptides. Additionally, we normalized SC using the following formula:
For analysis of the difference of abundance among the proteomes, proteins were divided into three groups according to SC: the high-abundance group (SC ‡ 50), the mediumabundance group (20 < SC < 49), and the low-abundance group (SC < 20). Significant upregulation was defined as an SC ratio ‡3 and SC distance ‡5; significant downregulation was defined as an SC ratio 0.33 and SC distance À5. The SC ratio was calculated from the equation SC ratio ¼ ðtear protein SC of diabetic patientsÞ=ðcontrol SCÞ;
and SC distance was calculated using the following formula:
SC distance ¼ ðtear protein SC of diabetic patientsÞ À ðcontrol SCÞ:
Statistical Analysis
The v 2 tests and Student's t-tests were performed using the SPSS statistical software (SPSS, Inc., Chicago, IL) and a P value of 0.05 or less was considered significant.
RESULTS
Demographic and Baseline Characteristics of the Study Subjects
Demographic and baseline characteristics of the study subjects are summarized in Table 2 . The subjects of the three groups were matched in age and sex. Patients with diabetes and dry eye syndrome had a median duration of diabetes of 11.37 (range, 7-20) years, which was markedly longer than that of patients with diabetes only (median, 9.25 years; range, 5-15 years, P < 0.01). The best corrected visual acuity in patients with diabetes and dry eye syndrome (OD, 0.38 6 0.25; OS, 0.53 6 0.38) was markedly lower than that of patients with diabetes only (OD, 0.78 6 0.32; OS, 0.78 6 0.34, P < 0.01). Tear BUT was significantly lower in both eyes in patients with diabetes and dry eye syndrome (OD, 3.38 6 3.07; OS, 2.75 6 3.24) than that of patients with diabetes only (OD, 9.25 6 5.52; OS, 8.25 6 5.73, P < 0.01). Tear secretion as revealed by the Schirmer I test also was markedly reduced in patients with diabetes and dry eye syndrome (OD, 2.5 6 2.39; OS, 4.0 6 6.70) compared to that of patients 
Patients With Diabetes and Dry Eye Syndrome Have Increased Normalized Protein Content in Tears
We determined further the normalized protein content in tear samples. The normalized tear protein content in patients with diabetes and dry eye syndrome was 1.19 6 0.7, which was markedly higher than that of patients with diabetes only (0.27 6 0.13, P ¼ 0.001) and normal healthy subjects (0.20 6 0.14, P ¼ 0.001, Fig. 1 ).
Tear Proteomic Characteristics of Patients With Diabetes and Dry Eye Syndrome
The 2D-nano-LC-MS/MS identified a total of 357 unique proteins from 4004 peptides from the tear samples, including 210 (58.8%) proteins in healthy subjects, 180 (50.4%) proteins in patients with diabetes, and 219 (61.4%) proteins in patients with diabetes and dry eye syndrome ( Fig. 2A) . The MS/MS spectra of complement C3 by 2D-nano-LC-MS/MS are shown in Figure 3 . Of the proteins, 91 (25.5%) were shared among healthy subjects, patients with diabetes, and patients with diabetes and dry eye syndrome. In addition, 6 (1.7%) proteins were found in healthy subjects and patients with diabetes only, 12 (3.4%) proteins were present in patients with diabetes only, and patients with diabetes and dry eye syndrome, including b2-microglobin and superoxide dismutase (Table 3) , and 50 (14.0%) proteins were shared by healthy subjects and patients with diabetes and dry eye syndrome. There were 63 (17.7%) proteins unique to healthy subjects, 71 (19.9%) proteins to patients with diabetes, and 66 (18.5%) to patients with diabetes and dry eye syndrome. The percentage of high and low abundance proteins was comparable among healthy subjects, patients with diabetes, and patients with diabetes and dry eye syndrome (P > 0.05, Fig. 2B ). Meanwhile, the percentage of medium abundance proteins in patients with diabetes and dry eye syndrome (12%) was markedly higher than that of healthy subjects (7%, P < 0.05). The functions of the proteins identified by the 2D-nano-LC-MS/MS technique were interpreted using the gene ontology tool available in the public domain at http://david.abcc.ncifcrf. gov/ (Fig. 2C) . The 10 most upregulated and downregulated proteins in the tear samples from each group are shown in Table 4 . Analysis of spectral counts of tear proteins showed that, compared to healthy controls, patients with diabetes and dry eye syndrome had increased expression of apoptosisrelated proteins, immunity-and inflammation-related proteins, and glycometabolism-related proteins ( Table 5 ). The interconnection of these proteins is shown in Figure 4 .
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DISCUSSION
Schirmer's strip has been used for collecting tears by investigators as it could well retain proteins, especially for tear samples of scant volume, for protein identification and quantification. One drawback is that the samples on the strip may become contaminated by unintentional contact with the conjunctival sac. Despite this drawback, Schirmer's strip still is considered by many investigators as an appropriate approach for collecting tear samples and could capture subtle changes in protein contents in the tear samples. 24, 25 In our study, we carried out a systematic comparison of tear proteomic properties of patients with type 2 diabetes and dry eye syndrome, patients with diabetes only, and normal subjects. Our D-LC-MS/MS identified 357 distinct proteins from tear samples of all subjects, and these proteins include proteins identified in a previous study, such aslactoferrin and lipocalin, 26 indicating that 2D-nano-LC-MS/MS is a suitable approach for obtaining rich protein information from biofluid, ) was present only in normal subjects, suggesting that some proteins present in normal tears are lost with development of diabetes or diabetes with dry eye syndrome. We further found that the expression of some proteins, such as complements, heat shock proteins, and annexins, is increased, while that of some other proteins, such as peroxiredoxin and superoxide proteins, is reduced, implying that changes in the proteome occur in diabetic patients before overt onset of dry eye syndrome. We also observed that patients with diabetes and dry eye syndrome exhibited increased expression of apoptosis-related proteins, immunity-and inflammation-related proteins, and glycometabolism-related proteins. These findings indicated different proteomic profiles in healthy subjects, patients with diabetes only, and patients with diabetes and dry eye syndrome. Srinivasan et al. 25 showed that certain proteins, such as ezrin, Ig gamma-3 chain C region, and peroxiredoxin, were upregulated, while other proteins, including cystatin-S, lacritin, lipocalin-1, proline-rich protein-4, lysozyme, polymeric immunoglobulin receptor, and lactotransferrin, were downregulated in patients with moderate to severe dry eye disease. Consistently, we also found that cystatin-S, proline-rich protein-4, and polymeric immunoglobulin receptor were downregulated in dry eye patients without diabetes compared to normal subjects. However, the polymeric immunoglobulin receptor was upregulated in diabetic patients with dry eye disease. Zhou et al. 27 reported that S100A8 and S100A9 upregulation correlated with severity of dry eye symptoms. In our study, we also found that S100A8 and S100A9 in tears of diabetic patients were upregulated compared to normal subjects. It has been reported that lipocalin-1 was downregulated in dry eye disease, 28 while in our study we found apparent upregulation of lipocalin-1 in diabetic patients without dry eye disease, but marked downregulation of the protein was observed in diabetic dry eye patients. We speculated lipocalin-1 downregulation may be an underlying cause of dry eye disease. Meanwhile, b2 microglobulin was downregulated in diabetic patients with or without dry eye, which is consistent with the report by Kim et al., 28 suggesting that B2M may be related to development of diabetes, but not Nano-Liquid Chromatography/Tandem Mass Spectrometry IOVS j January 2014 j Vol. 55 j No. 1 j 184 dry eye. We also found IGL@protein and heat shock protein70 (HSP70) were increased in diabetic patients compared to normal subjects, which was even more significantly increased in diabetic patients with dry eye disease. We speculated that IGL@protein and HSP70 may be related to the development of dry eye disease in diabetic patients. However, whether they can serve as markers for diabetic dry eye disease needs further investigation. It has been suggested that some initial events, such as chronic hyperglycemia, corneal nerve damage, and impairment of insulin action, may lead to alterations in tear films and the ocular surface of diabetic patients. Those events contribute to tissue injury and may create an environment for inflammation, as nonspecific response could increase and perpetuate ocular injury. Our study also revealed changes in proteins involved in inflammation and immune response. Complement C3, which was upregulated in patients with diabetes and dry eye syndrome, has a central role in the activation of the complement system, and IL-1a, IL-6, and IFN-c significantly enhance C3 secretion. 29 The C3b interferes with IL-12 and IL-10 production via an ERK MAPK-dependent mechanism. 30 Elastase 2, which was found only in patients with diabetes and dry eye syndrome in our study, belongs to the peptidase S1 family and induces IL-8 expression via an IL-1 receptorassociated kinase signaling pathway; these events involve cell surface membrane-bound toll-like receptor 4 (TLR4). 31 However, elastase 2 activates p38 MAP kinase, which upregulates NF-jB and AP-1 activities, thus, inducing IL-8 mRNA expression and protein synthesis. 32 Secreted orosomucoid proteins, which were upregulated only in tears of patients with diabetes and dry eye syndrome, function in modulating the activity of the immune system during the acute phase reaction. These findings suggest that inflammatory mediators may inhibit neural signals to the lacrimal gland, 33 thus, depriving the gland of trophic stimulation needed for its maintenance and resulting in its progressive destruction. The inflammatory alterations may impair biochemical events, culminating in reduced tear secretion and dry eye syndrome in diabetic patients.
Recently, increased awareness of oxidative stress damage and its relation with ocular surface damage have prompted researchers to unravel mechanisms in the development of dry eye syndrome. The toxic effect of reactive oxygen species and free radicals can be eliminated by enzymes, such as superoxide dismutase (SOD), which eliminates O 2À to produce H 2 O 2 . 34 Behndig et al. 35 reported the tears contain little SOD activity. We found that SOD level was reduced in the tear of dry eye syndromes in diabetic patients. We also identified 18 apoptosisrelated proteins. Among them, 15 proteins, including heat shock proteins, annexins, modulator of apoptosis 1, were markedly upregulated in diabetic patients with dry eye syndrome compared to healthy controls.
We also were interested in whether lipid metabolism, which is important for stabilizing tear films, was dysregulated in dry eye syndrome in diabetic patients. We found that lipid metabolism-related proteins, a-2-HS-glycoprotein, apolipoprotein A II, and A IV, were increased significantly in diabetic patients with dry eye syndrome. The a-2-HS-glycoprotein belongs to the fetuin family, and is associated with insulinmediated inhibition of lipolysis and stimulation of lipogenesis. 36 Apolipoprotein A IV is a major component of high density lipoprotein (HDL) and chylomicrons, and has a role in chylomicron and VLDL secretion and catabolism. Apolipoprotein A II may be a positional candidate gene for familial type 2 diabetes, 37 and apolipoprotein A II may stabilize HDL structure by associating with lipids and affect HDL metabolism. The findings suggest that lipid metabolism becomes dysregulated in tear films of diabetic patients.
In conclusion, we have demonstrated that dry eye syndrome in diabetic patients is associated with an altered proteomic profile with dysregulated expression of proteins involved in a variety of important cellular process, including inflammation, immunity, oxidative stress, and lipid and glucose metabolism. These findings suggested broad derangement in tear proteins in diabetic patients with dry eye syndrome. Further characterization of these proteins could provide potential diagnostic markers and therapeutic targets that may lead to better outcomes for these patients. Further studies are needed to elucidate changes in the signaling pathways whose proteins are expressed aberrantly in tear contents in diabetic patients with dry eye syndrome.
